For Michelle Bessiake, the path toward a PhD program at the University of Chicago was winding.
After graduating from Texas Southern University with a bachelor’s degree in chemistry, Bessiake took a few years off to decide whether to pursue her doctorate. She entered the immunoengineering program at the University of Chicago Pritzker School of Molecular Engineering (PME). Initially she wanted to research tissue engineering but after taking immunology classes she joined a lab focused on basic immunology research.
Through her studies at the university, Bessiake now focuses on understanding regulatory T cells (Tregs) and the diseases that manifest when they aren’t functional due to mutations in important genes. In humans this cause systemic autoimmunity, particularly a syndrome called immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome, which Medline Plus defines as an autoimmune condition that causes the body’s immune system to attack its own tissue and organs. Her research involves understanding how this complex cell type can impact the cells around them. Tregs can also have a contradictory role where it protects cancer cells, so understanding how these cells work could help lead to better cancer treatments, she explains.
“Big picture wise, if you can get a full understanding of [what’s] going on in the whole system, we can work harder [and] have more avenues with treatment,” Bessiake said.
While searching for her ideal graduate program, Bessiake said she sought out institutions where she could feel safe as a student and grow as a person. Ultimately, she chose the University of Chicago for multiple reasons. For one thing, her initial weekend visit to the university “felt a little bit like home for me,” she said. Another perk was being closer to her family, who now mostly live in Michigan and Indiana.